L aryngotracheal stenosis (LTS) is a broad set of diagnoses encompassing a heterogeneous group of fibroinflammatory conditions relating to narrowing of the glottis, supraglottis, subglottis, and trachea. 1 The subset of patients with isolated subglottic stenosis accounts for nearly half of LTS cases. 2 Idiopathic subglottic stenosis (iSGS) is a rare and slowly progressive condition with an unknown primary cause that results in fibrosis of the subglottic airway. It generally presents in otherwise healthy middle-aged white women with symptoms of dyspnea and stridor. [3] [4] [5] [6] Current management of iSGS relies on a combination of surgical and adjuvant therapies based on physician preference and individual patient needs. Many patients can be treated successfully through endoscopic intervention, but owing to the recurrent nature of iSGS, greater than 85% of these patients required repeated intervention within 5 years.
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OBJECTIVE To determine whether peak expiratory flow (PEF) can be used as a reliable and easily accessible biometric indicator of disease progression relative to other validated spirometry measures in patients with idiopathic subglottic stenosis. 14 Given the complexity of these measures, we sought to validate the simple measurement of PEF rate as a biometric measure of the degree of luminal obstruction and the likely need for procedural intervention for iSGS. By design, our study population was limited to patients with iSGS as an explanatory trial maximizing the discriminating potential of spirometry testing in an ideal situation. Given the homogeneous nature of this population's demographics and the tendency of the disease to follow a predictable course over time, the use of PFTs in evaluating these patients has the potential to reduce data variability and resolve small differences in the predictive abilities of the various spirometry values. The purpose of this study is to evaluate the ability of PEF, relative to the validated measures of TPF and EDI, to differentiate the degree of luminal obstruction and predict the receipt of surgical intervention in patients with iSGS. 
Methods

Study Population
The EDI and TPF Rate
The PEF was measured in liters per second and was reported as part of the standard spirometry output; PEF represents the maximum volume of air expired per minute or second during a single expiratory cycle. The EDI and TPF rate were calculated from each set of reported spirometry measurements. The EDI is the ratio of forced expiratory volume in 1 second (FEV1) measured in liters to PEF measured in liters per second multiplied by 100 (FEV1/PEF × 100). 14 The TPF is the sum of the PEF and the absolute value of the PIF measured from flowvolume loop (TPF = PEF + |PIF|).
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Statistical Analysis
Variables are expressed as means, with 95% CIs, SDs, or binomial percentages as appropriate. To account for multiple measurements per patient, a mixed models analysis with compound symmetry covariance structure was used to analyze the effect of Cotton-Myer grade of stenosis on spirometry performance. A post hoc analysis of PEF, TPF, and EDI values was performed using receiver operating characteristic (ROC) curves to predict receipt of surgical intervention. This analysis was accomplished by ascribing spirometry values collected during clinic visits to binary outcome variables of operative intervention or no operative intervention within 2 months of the clinic visit. Optimal cutoff values for distinguishing the 2 groups were determined as the point on the ROC curve closest to (0,1), maximizing values for both sensitivity and specificity. The FEV1 was also included on the ROC curve as a comparative measurement known to be relatively unaffected by degree of extrathoracic airway obstruction. 9 The AUCs for PEF, EDI, and TPF were compared with standardized ranges, in which 0.9 to 1.0 is considered excellent, 0.8 to 0.9 is good, 0.7 to 0.8 is fair, 0.6 to 0.7 is poor, and 0.5 to 0.6 is considered a failure. 17 Preoperative and postoperative EDI, PEF, and TPF values were plotted, and means and percentage change were calculated.
Results
Patient Characteristics
Data from 52 patients were collected. Four patients were excluded from analysis owning to coexisting glottic or supraglottic stenosis, and 6 patients were excluded owing to nonidiopathic etiology of SGS. Demographic data from the remaining 42 patients with iSGS are summarized in the Table. All 42 patients were female. Forty-one patients were white, and 1 was Hispanic. Mean (SD) age at diagnosis was 51.5 (9.8) years.
Key Points
Question Is peak expiratory flow (PEF) a clinically useful biometric indicator for degree of luminal obstruction and receipt of surgical intervention in idiopathic subglottic stenosis?
Findings In this medical record review of 42 women, PEF was adequately sensitive and specific for predicting receipt of operative intervention when using a threshold of less than 4.4 liters per second (264 L/min). This spirometry measure compares favorably with the more complex measures of expiratory disproportion index and total peak flow.
Meaning Measuring PEF is a simple, but valuable, clinical tool for monitoring progression of stenosis and predicting receipt of surgical intervention for idiopathic subglottic stenosis.
Twenty-five patients (60%) were obese (body mass index [BMI] calculated as weight in kilograms divided by height in meters squared, 30.0-34.9) or morbidly obese (BMI, >35.0). Four patients (10%) had a history of smoking, and none were current smokers. The study period ranged from 2 to 40 months per patient, with a mean follow-up period of 18.4 months. No patient had a prior open tracheal resection, comorbid lower airway, or parenchymal lung disease based on medical history, thorough initial airway history, and when indicated, full PFTs with bronchodilator challenge. The number of lifetime endoscopic procedures per patient, including those performed at an outside institution, ranged from 0 to 7 with a median of 2 at the time of study completion. One patient had no prior endoscopic procedures. At the time of endoscopic intervention, 1 patient (2%) had grade I stenosis, 27 patients (54%) had grade II stenosis, and 22 patients (44%) had grade III stenosis. There were 251 spirometry measurements available among 42 patients, with a range of 2 to 15 measurements per patient. 
PEF, EDI, and TPF vs Cotton-Myer Grade of Stenosis
Utility of EDI, PEF, and TPF to Predict Operative Intervention
The area under the ROC curve for PEF was 0.855 (95% CI, 0.784-0.926). The optimal cutoff value, defined as that which maximizes sensitivity and specificity for differentiating between PEF values measured at preoperative visits and PEF values measured at all other visits, was 4.4 liters per second (264 L/min), with a sensitivity and specificity of 84.4% and 82.0%, respectively. In descriptive terms, a PEF cutoff of greater than 4.4 liters per second would not identify 15.6% of patients who would receive surgery in the next 2 months. Similarly, this cutoff would also incorrectly identify 18.0% of patients as possibly receiving surgery within the next 2 months. The area under the ROC curve for EDI was 0.853 (95% CI, 0.782-0.925). The optimal cutoff value for differentiating between EDI values measured at preoperative visits and all other visits was greater than 54.0, with a sensitivity and specificity of 80.6% and 80.4%, respectively. According to these data, an EDI cutoff of greater than 54.0 would not identify 19% of patients who would receive surgery in the next 2 months and would incorrectly identify 20% of patients as possibly receiving surgery within the next 2 months. The area under the ROC curve for TPF was 0.836 (95% CI, 0.757-0.916). The optimal cutoff value using TPF was 7.4 liters per second (444 L/min), with a sensitivity and specificity of 86.4% and 78.0%, respectively. A TPF cutoff of greater than 7.4 liters per second would not identify 13.6% of patients who would receive surgery in the next 2 months and would incorrectly identify 22.0% of patients as possibly receiving surgery within the next 2 months. The AUC for PEF, EDI, and TPF fell within the good category on the basis of the ranges outlined in the Methods section. Figure 2 shows the ROC curves for PEF, EDI, TPF, and FEV1, and Figure 3 shows scatter plots demonstrating how the study population's PEF, EDI, and TPF values relate to the screening cutoffs. Of note, flow rate (TPF, PEF) and EDI follow an inverse relationship; for example, a low PEF or TPF and a high EDI are generally associated with a higher degree of stenosis. Figure 4 
Discussion
The natural history of iSGS requires monitoring for stenosis progression to determine the appropriate timing of surgical or procedural intervention. It is important to be able to objectively measure improvement to be able to compare novel treatments against the current standard of care. Currently, no formal recommendations exist regarding which spirometry indices have the greatest clinical utility for monitoring patients with iSGS. In this study, we compared the utility of the PEF with established spirometry markers, TPF and EDI, for differentiating the severity of airway compromise in iSGS. The data suggest that PEF, EDI, and TPF are equally sensitive and specific measures for monitoring stenosis progression and predicting the receipt of surgical intervention. While all 3 values are similar in their ability to accomplish these tasks, the simplicity of measurement and widespread use of PEF for monitoring various breathing conditions makes it a more physician-and patient-friendly value than EDI or TPF. Furthermore, PEF is routinely found on a standard spirometry report, whereas the EDI and TPF are calculated from values found on a standard report, thus requiring an extra step on the part of the clinician.
The sensitivity and specificity of the PEF for identifying patients who receive surgery within 2 months is characterized as good, 84.4% and 82.0%, respectively. For example, of 100 patients with iSGS for whom we would recommend surgical intervention, PEF, EDI, and TPF will identify 84, 80, and 86 of those patients, respectively. While these values are not perfect, we believe the PEF provides an additional piece of data on which to base clinical decision making when interpreted in the context of each patient's symptoms and physical examination and laryngoscopy findings.
This study validates and confirms previous studies on the utility of spirometry for monitoring upper airway stenosis. We found significant differences in mean EDI, PEF, and TPF values among patients with different Cotton-Myer grades of subglottic stenosis, which compares favorably with data published in 2013 by Nouraei et al 9 and in 2014 by Nouraei et al. 14 Our data also support the use of the PEF to identify treatment-related changes, given the significant difference between mean preoperative and postoperative values. According to data published by Nouraei et al 14 in 2014, the change in the AUC for the flow-volume loop divided by FVC (ΔAUC total /FVC) was superior to the PEF and TPF for identifying treatment-related changes in patients with LTS.
14 However, the ΔAUC total /FVC is not a clinically accessible value because it requires specialized software to calculate the area under the flow-volume loop. The PEF, in contrast, can be determined with a quick glance at the flow-volume loop or spirometry report. The receiver operating characteristic curves demonstrate the sensitivity and specifity of the peak expiratory flow (PEF), expiratory disproportion index (EDI), total peak flow (TPF), and forced expiratory volume in 1 second (FEV1) for differentiating spirometry measures taken at preoperative visits and all other visits. AUC indicates area under the receiver operating curve. It must be noted that the PEF is less useful than EDI for the initial diagnosis of subglottic stenosis. EDI has been shown to be a highly sensitive and specific tool for differentiating subglottic stenosis from parenchymal lung disease and lower airway disease. 9 However, based on the data presented in this study, once a diagnosis is established, PEF can be used for longitudinal clinical surveillance. Our analysis showed that a specific threshold of greater than 4.4 liters per second can be used as an indicator that a patient is approaching operative intervention. While no single piece of data will replace a thorough history and physical examination and no single laboratory value can be used to identify patients for whom surgical intervention is appropriate, we believe that PEF can serve as a valuable adjunct to clinic-based care. With regard to future study and application, our findings may be particularly relevant to patients in areas where access to care is poor who could benefit from telemedicine consultation between an airway specialist and their primary care clinician when regular travel to an airway center is not possible. This approach would be most reliable when the progression of disease is relatively predictable, as in iSGS, and does not preclude the need for longitudinal follow-up for airway visualization and to assess issues that may not be trackable on spirometry.
Limitations
The main limitation of this study is the relatively small number of patients and spirometry values used in the data analysis, particularly in the Cotton-Myer grade III group. Furthermore, each patient contributed a variable number of spirometry values over different time frames on the basis of the clinical need for visit frequency. As a result, those with more severe disease are seen in clinic more frequently and therefore have a disproportionate share of the spirometry values. A more structured data set would include spirometry values from standard benchmarks during each patient's course of disease. 
